Australia markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.5599-0.0243 (-4.16%)
At close: 04:00PM EDT
0.5543 -0.01 (-1.00%)
After hours: 04:19PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
126,325
126,325
7,128
144,927
33,215
Operating expenses
Research development
145,860
145,860
172,920
141,891
90,570
Selling general and administrative
87,744
87,744
79,694
69,261
30,775
Total operating expenses
234,308
234,308
253,618
209,420
121,345
Operating income or loss
-107,983
-107,983
-246,490
-64,493
-88,130
Interest expense
13,176
13,176
6,020
2,910
2,924
Total other income/expenses net
134
134
-705
-1,045
981
Income before tax
-113,724
-113,724
-250,157
-65,578
-89,127
Income from continuing operations
-113,724
-113,724
-250,157
-65,578
-89,127
Net income
-113,724
-113,724
-250,157
-65,578
-89,127
Net income available to common shareholders
-113,724
-113,724
-250,157
-65,578
-89,127
Basic EPS
-1.11
-
-2.31
-0.72
-1.12
Diluted EPS
-1.11
-
-2.31
-0.72
-1.12
Basic average shares
126,765
-
108,077
91,703
79,789
Diluted average shares
126,765
-
108,077
91,703
79,789